Earnings Ahead

AMGN - Amgen Inc

340.16 -5.26 -1.52

Amgen Inc

Amgen Inc

About

Profile

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.


Headquarters

Thousand Oaks, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AMGN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Amgen’s obesity prospects in focus ahead of Q4 results
  • Amgen weight loss drug shows promising early data
  • Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
  • Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz
  • U.S. govt. opens bids in Medicare drug price negotiations
  • Big Pharma earnings season in spotlight amid positive sentiment
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • FDA issues boxed warning for Amgen's osteoporosis drug
  • Honeywell's quantum computing firm valued at $5B after new fund raising round
  • Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)
  • Amgen in pact with Xeris Biopharma for Tepezza injectable
  • Florida wins FDA nod for mass drug imports from Canada (update)
  • Morgan Stanley positive on healthcare services despite election year
  • Pharma and biotech deal values spike 35% in 2023: report
  • Amgen says FDA declined full approval for lung cancer drug Lumakras
  • Amgen upgraded by BMO on underappreciated opportunity in obesity/metabolic space
  • Dividend Roundup: Alibaba, Amgen, AT&T, Southwest Airlines, and more
  • AbbVie, Amgen among firms targeted for latest Medicare inflation penalties
  • Amgen names former Novartis exec James Bradner as chief scientific officer
  • Amgen gets FDA priority review for small cell lung cancer drug

Earnings History

Date EPS / Forecast Revenue / Forecast
February 7, 2022 4.36 / 4.07 6.85B / 6.88B
November 2, 2021 4.67 / 4.29 6.71B / 6.67B Beat!
August 3, 2021 4.38 / 4.09 6.53B / 6.46B Beat!
April 27, 2021 3.7 / 4.05 5.9B / 6.26B
February 2, 2021 3.81 / 3.36 6.63B / 6.57B Beat!
October 28, 2020 4.37 / 3.93 6.42B / 6.39B Beat!
July 28, 2020 4.25 / 3.82 6.21B / 6.19B Beat!
April 30, 2020 4.17 / 3.74 6.16B / 6B Beat!
January 30, 2020 3.64 / 3.41 6.2B / 6.03B Beat!
October 29, 2019 3.66 / 3.53 5.74B / 5.63B Beat!
July 30, 2019 3.97 / 3.59 5.87B / 5.69B Beat!
April 30, 2019 3.56 / 3.48 5.56B / 5.53B Beat!
January 29, 2019 3.42 / 3.27 6.23B / 5.84B Beat!
October 30, 2018 3.69 / 3.45 5.9B / 5.78B Beat!
July 26, 2018 3.83 / 3.54 6.06B / 5.72B Beat!
April 24, 2018 3.47 / 3.22 5.55B / 5.43B Beat!
February 1, 2018 2.89 / 3.03 5.80B / 5,828M
October 25, 2017 3.27 / 3.11 5.77B / 5,756M Beat!
July 25, 2017 3.27 / 3.11 5.81B / 5.67B Beat!
April 26, 2017 3.15 / 3.11 5.46B / - Beat!
February 2, 2017 2.89 / 2.99 5.97B / 5.77B Beat!
October 27, 2016 3.02 / 2.81 5.81B / 5.71B Beat!
Date Price Open High Low Vol Change
Dec 4 340.16 344.23
346.08
338.95
3.3M -1.52%
Dec 3 345.42 340.54
346.38
338.85
2.8M 2.09%
Dec 2 338.36 338.86
342.5
336.33
2.4M 0.26%
Dec 1 337.49 343.07
343.98
336.25
2.4M -2.31%
Nov 28 345.46 344
345.66
342.26
1.3M 0.26%
 
Nov 26 344.57 341.52
345.03
340
2.3M 1.01%
Nov 25 341.11 335.41
341.73
335.41
2.9M 2.04%
Nov 24 334.3 335.84
338.66
331.7
3.6M -0.96%
Nov 21 337.54 334.87
342.84
334.74
4.1M 0.44%
Nov 20 336.07 344.52
345.09
335
3.2M -1.85%
Nov 19 342.4 343.47
345.29
340.02
2.1M -0.46%
Nov 18 343.99 343.73
345.49
339.3
3.0M 0.67%
Nov 17 341.71 337.64
344.06
336.83
3.0M 1.48%
Nov 14 336.74 336.74
339.8
330.35
3.3M 0.22%
Nov 13 336 337.9
345.84
335.12
3.4M -0.08%
Nov 12 336.28 338.64
342.4
335.82
2.9M -0.64%
Nov 11 338.45 323.42
338.55
323.42
3.1M 4.57%
Nov 10 323.66 320.6
326.18
319.54
2.5M 1.08%
Nov 7 320.2 316.08
321.42
314
2.7M 1.46%
Nov 6 315.59 319.1
321.31
312.52
3.3M -1.33%
Nov 5 319.86 303.13
322.98
302.13
5.5M 7.81%
Nov 4 296.7 298.71
299.06
294.48
3.4M 0.13%
Nov 3 296.3 298.43
301
292.12
2.8M -0.71%
Oct 31 298.43 288.46
298.88
288
2.7M 2.20%
Oct 30 292 290.58
294.56
289
2.1M 0.08%
Oct 29 291.77 291.76
294.81
289.44
2.8M -0.11%
Oct 28 292.09 288.93
292.63
288.26
2.2M 0.32%
Oct 27 291.16 291.21
292
288.26
1.8M -0.21%
Oct 24 291.76 292.89
293.94
290.66
1.4M -0.39%
Oct 23 292.89 296.01
296.46
291.91
1.5M -1.04%
Oct 22 295.98 301.29
302.82
295.6
1.7M -1.71%
Oct 21 301.14 302.6
303.85
298.03
1.5M -0.72%
Oct 20 303.33 299.48
303.66
297.75
1.6M 1.51%
Oct 17 298.81 295.24
299.37
293.14
2.0M 1.01%
Oct 16 295.81 298.07
302.27
294.44
1.7M -0.51%
Oct 15 297.32 292.82
298.21
292.43
2.5M 1.18%
Oct 14 293.85 291.74
296.87
290.97
2.0M 0.50%
Oct 13 292.4 291.74
296.13
289.44
1.8M 0.78%
Oct 10 290.13 296.16
297.09
289.58
2.7M -1.79%
Oct 9 295.43 294.13
296.63
293.7
1.4M 0.27%
Oct 8 294.62 295.79
297.63
292.29
2.9M -0.31%
Oct 7 295.54 293.27
295.85
290.21
1.5M 0.48%
Oct 6 294.12 297.62
297.62
293.03
2.0M -1.27%
Oct 3 297.89 297.72
301.54
295.63
2.5M 0.16%
Oct 2 297.4 298.31
300.5
295.46
2.1M -0.37%
Oct 1 298.5 284.45
301.66
283
4.8M 5.78%
Sep 30 282.2 274.14
284.82
274.02
3.5M 3%
Sep 29 273.97 273.1
274.52
270.67
1.8M 0.36%
Sep 26 272.98 274.34
275.5
269.77
1.8M 0.66%
Sep 25 271.18 279
281.05
270.64
2.8M -2.88%
Sep 24 279.22 285.47
286.7
278
2.4M -2.65%
Sep 23 286.81 283.96
287.26
283.96
2.3M 0.28%
Sep 22 286 284.13
287.2
281.71
3.1M 0.21%
Sep 19 285.41 278.64
286.15
277.37
8.7M 3.47%
Sep 18 275.83 274.7
276.5
273.97
3.3M 0.41%
Sep 17 274.71 274.14
277.8
273
1.7M 0.60%
Sep 16 273.08 275.89
277.59
271.73
2.2M -0.48%
Sep 15 274.4 276.07
277.24
271.61
2.6M -0.72%
Sep 12 276.39 281.04
282.94
276.07
2.1M -2.24%
Sep 11 282.73 278.52
282.9
278
2.2M 0%